Serum endothelial injury markers in hemodialysis patients with arteriovenous fistula stenosis

Autor: Saito, Osamu, Kotouda, Atushi, Saito, Takako, Sugase, Taro, Akimoto, Tetsu, Ando, Yasuhiro, Muto, Shigeaki, Kusano, Eiji
Jazyk: angličtina
Rok vydání: 2013
Předmět:
Zdroj: 自治医科大学紀要 = Jichi Medical University Journal. 35:1-6
ISSN: 1881-252X
Popis: Background: In hemodialysis patients, failure of arteriovenous fistula (AVF) is a serious problem. AVF stenosis is dominant cause of vascular access failure. We hypothesized that vascular endothelial damage may be involved in arteriovenous fistula (AVF) stenosis. Methods: A cross-sectional observational survey was performed in 122 patients receiving maintenance hemodialysis in January-April 2004. Serum levels of adiponectin, adhesion molecules (intercellular adhesion molecule-1; ICAM-1 and vascular cell adhesion molecule-1; VCAM-1), and endothelial injury markers (CD146 and thrombomodulin) were compared between 46 patients with AVF stenosis and 76 patients without AVF stenosis to determine factors associated with AVF stenosis. Results: The serum adiponectin level was significantly lower in patients with AVF stenosis compared to those without AVF stenosis. Similarly, the serum levels of ICAM-1 and thrombomodulin were significantly lower in patients with AVF stenosis, whereas the serum level of VCAM-1 was significantly higher in patients with AVF stenosis. There were no significant differences in other parameters between the two groups. Logistic regression analysis with the presence or absence of AVF stenosis as the dependent variable showed that administration of an antihypertensive drug, VCAM-1, ICAM-1 and thrombomodulin were significantly associated with the presence of AVF stenosis in hemodialysis patients. Conclusion: The significant associations of administration of an antihypertensive drug, VCAM-1, ICAM-1 and thrombomodulin with AVF stenosis suggest that endothelial injury may play a critical role in this condition.
Databáze: OpenAIRE